Key facts
- This page summarizes Christopher I. Wright's Form 4 filing for Alkermes plc. (ALKS).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 08 Jul 2022, 16:25.
Christopher I. Wright - 07 Jul 2022 Form 4 Insider Report for Alkermes plc. (ALKS)
- Reporting relationship
- Director
- Issuer ticker
- ALKS
- Reported as of
- 07 Jul 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Jul 2022, 16:25:46 UTC
- Prior SEC filing
- 10 Jun 2022
- Next SEC filing
- 12 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shantale Greenson, attorney-in-fact for Christopher I. Wright
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher I. Wright filed Form 4 for Alkermes plc. (ALKS) on 08 Jul 2022.
Change
- Previous filing in this sequence was filed on 10 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ALKS
transaction
Derivative
Restricted Stock Unit Award
Award
- Transaction value
- $0
- Shares
- +5,957
- Change %
- Price
- $0.000000
- Shares after
- 5,957
- Date
- 07 Jul 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 5,957
- Exercise price
- Footnotes
- F1, F2
ALKS
transaction
Derivative
Non Qualified Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +11,554
- Change %
- Price
- $0.000000
- Shares after
- 11,554
- Date
- 07 Jul 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 11,554
- Exercise price
- $31.48
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one ordinary share.
Footnote F2
Shares subject to the restricted stock unit award vest in full on 7/7/2023.
Footnote F3
Shares subject to the stock option award vest and become exercisable in full on 7/7/2023.